<unk>  is a meglitinide and biguanide combination that is FDA approved for the {{{indicationType}}} of type 2 diabetes mellitus who are already treated with a meglitinide and<unk>  HCl or who have inadequate glycemic control on a meglitinide alone or<unk>  HCl alone. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include hypoglycemia, headache, diarrhea, nausea and vomiting.
Repaglinide and Metformin hydrochloride
Glyburide and Metformin hydrochloride
Linagliptin and Metformin hydrochloride
Saxagliptin hydrochloride and Metformin hydrochloride
Pioglitazone And Metformin hydrochloride
Sitagliptin And Metformin Hydrochloride
Dapagliflozin / saxagliptin
Pioglitazone/Glimepiride